ARCL Organics Ltd

ARCL Organics Limited has received a Final Order dated October 6, 2026, from the Debts Recovery Tribunal -I, Kolkata, concluding case OA/86/2005 concerning the Stressed Assets Stabilisation Fund versus Allied Resins and Chemicals Ltd. (now ARCL Organics Limited). The Tribunal recorded that the company fulfilled a settlement agreement by paying Rs 8,22,94,500 as the settlement amount and Rs 21,95,394 towards interest, thereby satisfying the Applicant Bank's claim and disposing of the case. As a result of this resolution, ARCL Organics Limited anticipates obtaining a No Objection Certificate and release of charges on land properties offered as security, including the land at Rampur where its manufacturing operations are located.

ARCL Organics Limited informed the BSE Limited that it has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026, confirming the details of securities dematerialized during that period were furnished to all listed stock exchanges, with confirmation from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited.

ARCL Organics Limited informed the Bombay Stock Exchange that the trading window for dealing in the company's securities will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026, in accordance with the company’s code of conduct and Securities and Exchange Board of India regulations.

ARCL Organics Limited announced that its Board of Directors approved the appointment of Mr. Deepak Daga as Company Secretary and Compliance Officer, effective September 16, 2026, to comply with the provisions of Section 203 of the Companies Act, 2013 and Regulation 6 under SEBI LODR Regulations, 2015.

ARCL Organics Limited announced that its board of directors approved the appointment of Mr. Deepak Daga as Company Secretary and Compliance Officer, effective September 16, 2026, to comply with the provisions of Section 203 of the Companies Act, 2013 and Regulation 6 under SEBI LODR Regulations, 2015.

ARCL Organics Ltd share price slipped 1.78% to Rs 217.55. The Company's net profit saw a strong growth of 226.88% to Rs 9.12 crore, while revenue from operations slightly gained 2.51% to Rs 66.95 crore in Q2FY26 over Q1FY26. The market capitalization of Commodity Chemicals industry group stocks on BSE stood at Rs 1.65 lakh crore, gaining 9.80%. It has softened by 1.74% over last one week and softened by 0.58% in last one month while the market capitalization of ARCL Organics Ltd has slipped by 1.72% and 18.78% in the same period respectively. Profit before tax (PBT) of ARCL Organics Ltd stood at Rs 12.91 crore in Q2 FY26, surging by 162.40% year-on-year, and rallying 188.17% quarter-on-quarter. EBITDA came in at Rs 15 crore, jumping 161.10% YoY and expanding by 133.33% sequentially. Total expenses contracted by 11.09% to Rs 53.22 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 31.47 crore, slumping by 30.27% YoY, while employee benefits expense was at Rs 3.49 crore, rising by 10.79% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 31.39% to Rs 250.59 crore, while net profit saw a mild growth of 9.12% to Rs 12.33 crore, compared to previous TTM. EBITDA jumped by 1653% to Rs 21.46 crore, and PBT rose 14.33% to Rs 16.75 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.35 crore in FY26, as against Rs 12.82 crore in FY25. ARCL Organics Ltd nosedived by 14.13% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.04% during the same period.

ARCL Organics Limited will hold a meeting of its Board of Directors on Wednesday, August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with the Independent Auditor’s Limited Review Report, and the trading window for directors, officers, and designated persons will remain closed until 48 hours after the results are made public.

Net profit of ARCL Organics declined 50.18% to Rs 2.79 crore in the quarter ended March 2026 as against Rs 5.60 crore during the previous quarter ended March 2025. Sales declined 9.59% to Rs 65.31 crore in the quarter ended March 2026 as against Rs 72.24 crore during the previous quarter ended March 2025. For the full year,net profit declined 57.91% to Rs 5.19 crore in the year ended March 2026 as against Rs 12.33 crore during the previous year ended March 2025. Sales rose 8.67% to Rs 272.31 crore in the year ended March 2026 as against Rs 250.59 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales65.3172.24 -10 272.31250.59 9 OPM %10.8612.39 -9.059.50 - PBDT6.128.28 -26 23.6221.96 8 PBT4.486.86 -35 17.6016.75 5 NP2.795.60 -50 5.1912.33 -58 Powered by Capital Market - Live

ARCL Organics will hold a meeting of the Board of Directors of the Company on 7 May 2026.

Net loss of ARCL Organics reported to Rs 8.81 crore in the quarter ended December 2025 as against net profit of Rs 1.79 crore during the previous quarter ended December 2024. Sales declined 13.70% to Rs 53.47 crore in the quarter ended December 2025 as against Rs 61.96 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales53.4761.96 -14 OPM %-0.606.15 - PBDT-0.563.67 PL PBT-2.072.38 PL NP-8.811.79 PL Powered by Capital Market - Live